Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Pieter C. Smits, Yoshinobu Onuma et al.|New England Journal of Medicine|2021Cited by 571
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C. Smits, Enrico Frigoli, Jan G.P. Tijssen et al.|Circulation|2021Cited by 77
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Marco Valgimigli, Pieter C. Smits et al.|American Heart Journal|2018Cited by 62
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskPieter C. Smits, Marco Valgimigli, Enrico Frigoli et al.|Journal of the American College of Cardiology|2022Cited by 34
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding RiskAntonio Landi, Marco Roffi, Mirvat Alasnag et al.|JAMA Cardiology|2023Cited by 30